Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Perrigo Company Stories

2012-11-28 08:30:40

ALLEGAN, Mich., Nov. 28, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Ofirmev® (acetaminophen) injection brought by Cadence Pharmaceuticals, Inc. ("Cadence"). Under the terms of the settlement, Perrigo can launch a generic version of Ofirmev® (acetaminophen) injection on December 6, 2020, or earlier under certain circumstances. In addition, Perrigo has secured the right to be the sole...

2012-11-27 12:30:10

ALLEGAN, Mich., Nov. 27, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for betamethasone valerate foam 0.12%, the generic equivalent of Luxiq® Foam. Perrigo has manufactured the product and is preparing to commence commercial shipments on January 15, 2013, consistent with the date certain launch...

2012-11-13 16:26:08

ALLEGAN, Mich., Nov. 13, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Credit Suisse Healthcare Conference on Wednesday, November 14, 2012 at The Arizona Biltmore Hotel in Phoenix, AZ at 4:30 PM (MST). From its beginnings as a packager of generic home remedies in 1887, Perrigo Company, based in Allegan, Michigan, has grown to become a leading global provider of quality, affordable...

2012-11-13 16:25:31

ALLEGAN, Mich., Nov. 13, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote® (acetylcysteine) injection brought by Cumberland Pharmaceuticals, Inc. ("Cumberland"). Under the terms of the settlement, Perrigo can launch a generic version of Acetadote® (acetylcysteine) injection upon expiration of the patents in May 2026. In addition, Perrigo entered into an agreement with Cumberland...

2012-11-07 08:27:44

ALLEGAN, Mich., Nov. 7, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE: PRGO) today announced results for its first quarter ended September 29, 2012. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Perrigo's Chairman and CEO Joseph C. Papa commented, "We have started fiscal 2013 well, delivering record first quarter revenue and adjusted earnings. We also delivered all-time record adjusted gross and operating margins. Store brand OTC market share continues to grow....

2012-11-06 16:27:44

ALLEGAN, Mich., Nov. 6, 2012 /PRNewswire/ -- The Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors has appointed Jacqualyn A. Fouse, Ph.D. as a new director of the Company. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Perrigo's Chairman, President and CEO Joseph C. Papa stated, "Jackie's outstanding background has served her well in leadership roles at several pharmaceutical and healthcare companies. Her broad business and strategic acumen...

2012-10-16 07:28:02

ALLEGAN, Mich., Oct. 16, 2012 /PRNewswire/ -- The Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to market over-the-counter (OTC) omeprazole and sodium bicarbonate capsules 20mg/1100mg, the store brand equivalent to Merck & Co.'s Zegerid OTC®. Perrigo expects to launch the product on the date when market formation occurs. (Logo:...

2012-10-10 07:28:27

ALLEGAN, Mich., Oct. 10, 2012 /PRNewswire/ -- The Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDA) to market over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor). (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) This ANDA approval represents the first approval for mini lozenge products that will be...

2012-10-01 06:26:35

ALLEGAN, Mich., Oct. 1, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has closed the acquisition of Sergeant's Pet Care Products, Inc. (Sergeant's), a privately-held, Omaha, Nebraska-based manufacturer of over-the-counter companion animal healthcare products, for approximately $285 million in cash. As previously highlighted, Perrigo expects to receive a significant tax benefit generated from the amortization of the step-up in tax basis resulting from the...

2012-09-18 02:28:56

ALLEGAN, Mich., Sept. 18, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer Judy Brown will present at the UBS Global Life Sciences Conference on Wednesday, September 19, 2012 at the Grand Hyatt Hotel in New York, NY at 3:00 PM EST. From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality,...